| BLS Pharmaceuticals Limited (BLS) ORDINARY FULLY PAID |
Consumer Staple |
$215 |
BLS Pharmaceuticals Investor Webinar Presentation
|
30 Jul 2026 8:57AM |
$0.780 |
$0.935 |
risen by
19.87%
|
|
BLS - Price-sensitive ASX Announcement
Full Release
Key Points
- Record FY2026 revenue of $75 million.
- Strong cash flow with $6.3 million in Q4 FY2026.
- Strategic expansion in the UK, Europe, and LATAM.
- GMP-certified manufacturing for cannabis, psilocybin, and MDMA.
- Advanced drug delivery and expansion into ibogaine and peptides.
- Robust international partnerships and supply agreements.
- Leadership led by CEO Samuel Watson with strategic growth focus.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Barton Gold Holdings Limited (BGD) ORDINARY FULLY PAID |
Materials |
$264 |
Further Assays Infill Tunkillia Pit Extension Targets
|
30 Jul 2026 8:56AM |
$0.710 |
$0.975 |
risen by
37.32%
|
|
BGD - Price-sensitive ASX Announcement
Full Release
Key Points
- Phase 2 drilling nearing completion at Tunkillia Gold Project
- Significant assays reported from Area 223 North and southern 'Area 223'
- Broad intersections with promising gold grades identified
- Tunkillia aims for 120,000oz gold and 250,000oz silver annual production
- NPV of A$1.4 billion and IRR of 73.2% reported
- Expected completion of PFS and submission of mining lease application
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| IRIS Metals Limited (IR1) ORDINARY FULLY PAID |
Materials |
$14 |
IR1 REALISES AU$285,000 FROM SALE OF ARIKA RESOURCES SHARES
|
30 Jul 2026 8:55AM |
$0.054 |
$0.048 |
fallen by
11.11%
|
|
| Axel REE Limited (AXL) ORDINARY FULLY PAID |
Materials |
$11 |
Caldas South Identified as New ISR REE Target
|
30 Jul 2026 8:55AM |
$0.060 |
$0.065 |
risen by
8.33%
|
|
AXL - Price-sensitive ASX Announcement
Full Release
Key Points
- Caldas South identified as a new target for ISR rare earth elements (REE) exploration.
- 28 auger holes drilled across seven exploration licenses at Caldas South.
- Potential for Caldas South to develop as a mineralised district similar to the Caladão Project.
- Focus on permeability, hydraulic continuity, containment, and recoverability at Caldas South.
- Results from Caldas South may expand Axel REE Limited's portfolio of ionic REE systems.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Janus Electric Holdings Limited (JNS) ORDINARY FULLY PAID |
Utilities |
$60 |
Cleansing Prospectus
|
30 Jul 2026 8:55AM |
$0.265 |
$0.370 |
risen by
39.62%
|
|
| PhosCo Ltd (PHO) ORDINARY FULLY PAID |
Materials |
$76 |
June 2026 Quarterly Activities and Cashflow Report
|
30 Jul 2026 8:54AM |
$0.130 |
$0.140 |
risen by
7.69%
|
|
PHO - Price-sensitive ASX Announcement
Full Release
Key Points
- Gasaat Phosphate Project resources increased to 166.6Mt at 20.6% P2O5.
- New discoveries at KH and DOH prospects.
- Maiden resource estimate for KM and SAB deposits announced.
- Single-stage flotation process for commercial-grade phosphate.
- Financially positioned with A$5.9 million in cash and EBRD support.
- Updated Scoping Study to be released next quarter.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Viking Mines Limited (VKA) ORDINARY FULLY PAID |
Materials |
$23 |
Quarterly Report for the period ended 30 June 2026
|
30 Jul 2026 8:54AM |
$0.010 |
$0.009 |
fallen by
10%
|
|
VKA - Price-sensitive ASX Announcement
Full Release
Key Points
- Viking Mines Limited focused on advancing the Linka Tungsten Project in Nevada, USA.
- The company completed a geophysical program confirming the presence of tungsten.
- They are progressing with a maiden drilling campaign set to begin soon.
- Viking divested the First Hit Gold Project in Western Australia to concentrate on tungsten.
- Cash reserves stood at $3.67M at the end of June 2026.
- Tungsten prices remained high, enhancing the strategic value of their projects.
- Viking's shares are now trading on the US OTC Markets under the ticker VKALF.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Sovereign Metals Limited (SVM) ORDINARY FULLY PAID |
Materials |
$354 |
June 2026 Quarterly Report
|
30 Jul 2026 8:53AM |
$0.520 |
$0.540 |
risen by
3.85%
|
|
SVM - Price-sensitive ASX Announcement
Full Release
Key Points
- Kasiya's Definitive Feasibility Study completed, projecting a 25-year life of mine.
- Focus on supplying critical minerals like rutile and graphite to US and allied markets.
- Significant cash outflows for exploration and evaluation activities.
- Completion of rehabilitation trials and strong community engagement initiatives.
- No mining or production activities occurred in the reported quarter.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Vanguard US Total Market Shares Index ETF (VTS) |
Financials |
$7,205 |
Supplement to the US Prospectus and Statement of Additional
|
30 Jul 2026 8:53AM |
$525.340 |
$540.330 |
risen by
2.85%
|
|
| Breakthrough Minerals Limited (BTM) ORDINARY FULLY PAID |
Energy |
$28 |
Notification regarding unquoted securities - BTM
|
30 Jul 2026 8:53AM |
$0.160 |
$0.145 |
fallen by
9.38%
|
|
| Black Rock Mining Limited (BKT) ORDINARY FULLY PAID |
Materials |
$24 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
30 Jul 2026 8:52AM |
$0.011 |
$0.011 |
fallen by
0%
|
|
BKT - Price-sensitive ASX Announcement
Full Release
Key Points
- Extension of US$204m credit facility deadline to 30 November 2026.
- Focus on early works for Mahenge Graphite Project in Tanzania.
- Completion of compensation payments for access road.
- Awarding of bulk earthworks contract to Taifa Mining and Civils Limited.
- Connection to hydro-dominated power enhances project sustainability.
- Net cash outflow from operating activities was A$1.77 million.
- Cash reserves of A$4.9 million at quarter-end.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Fitzroy River Corporation Ltd (FZR) ORDINARY FULLY PAID |
Energy |
$28 |
Quarterly Activities & Cashflow Report
|
30 Jul 2026 8:52AM |
$0.225 |
$0.255 |
risen by
13.33%
|
|
FZR - Price-sensitive ASX Announcement
Full Release
Key Points
- Fitzroy River Corporation Ltd (ASX: FZR) reported on activities for the quarter ended 30 June 2026.
- Royalty income from Weeks Royalty amounted to $116,897 for the March 2026 quarter.
- Total royalty receipts for the 12 months to 30 June 2026 were $551,260 compared to $633,379 in the prior corresponding period.
- Snowy River Gold Project buyout option by Tasman could be invalid; proceedings commenced in the New Zealand High Court.
- Bowdens Silver Project's Definitive Feasibility Study results released on 21 July 2026.
- Cash inflows included $12,265,134 from Endura related to Snowy River Royalty buyout option.
- Buru targeting a Final Investment Decision for the Rafael Gas Project by June 2027.
- Sam’s Creek Gold Project's mining permit application was declined, affecting Fitzroy's royalty rights.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Cambium Bio Limited (CMB) ORDINARY FULLY PAID |
Health Care |
$12 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
30 Jul 2026 8:51AM |
$0.430 |
$0.400 |
fallen by
6.98%
|
|
CMB - Price-sensitive ASX Announcement
Full Release
Key Points
- Net operating cash outflow of A$0.799 million for the quarter.
- Receipts from customers amounted to A$0.150 million.
- Research and development expenses were A$0.654 million.
- Closing cash balance was A$1.104 million as of 30 June 2026.
- The company expects a research and development tax incentive rebate for FY2026.
- A placement to raise A$1.008 million was announced post quarter end.
- The pivotal Phase 3 study design, CAMOMILE-2, was finalised.
- No investing cash flows were recorded during the quarter.
- A net financing cash outflow of A$0.261 million was due to loan repayments.
- Estimated quarters of funding available are less than two.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Prominence Energy Limited (PRM) ORDINARY FULLY PAID |
Energy |
$4 |
Prominence Appoints Chief Financial Officer
|
30 Jul 2026 8:51AM |
$0.002 |
$0.002 |
fallen by
0%
|
|
| FleetPartners Group Limited (FPR) ORDINARY FULLY PAID |
Financials |
$897 |
Update - Notification of buy-back - FPR
|
30 Jul 2026 8:50AM |
$2.890 |
$4.200 |
risen by
45.33%
|
|
| Block, Inc. (XYZ) CDI 1:1 FOREIGN EXEMPT NYSE |
Financials |
$4,424 |
Statement of Changes in Beneficial Ownership
|
30 Jul 2026 8:50AM |
$118.010 |
$116.580 |
fallen by
1.21%
|
|
| Breakthrough Minerals Limited (BTM) ORDINARY FULLY PAID |
Energy |
$28 |
Application for quotation of securities - BTM
|
30 Jul 2026 8:49AM |
$0.160 |
$0.145 |
fallen by
9.38%
|
|
| Dimerix Limited (DXB) ORDINARY FULLY PAID |
Health Care |
$180 |
Dimerix Quarterly Activities Report and Appendix 4C
|
30 Jul 2026 8:49AM |
$0.240 |
$0.300 |
risen by
25%
|
|
DXB - Price-sensitive ASX Announcement
Full Release
Key Points
- Dimerix executed a licensing agreement with Everest Medicines for Greater China, South Korea, and Southeast Asia.
- Dimerix is eligible to receive up to approximately A$481 million from the Everest transaction.
- The aggregate value of all licensing agreements increased to approximately A$1.9 billion in potential milestone payments.
- The ACTION3 Phase 3 study of DMX-200 in FSGS remains statistically powered to demonstrate treatment effects.
- Dimerix acquired DMX-652, expanding its kidney disease development pipeline.
- U.S. patent granted for DMX-652, providing protection through at least 2043.
- A$10 million non-dilutive funding secured to support pipeline expansion.
- Dimerix is funded through to completion of the ACTION3 Phase 3 trial for DMX-200 and initiation of the Phase 2 trial for DMX-652.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| IPD Group Ltd (IPG) ORDINARY FULLY PAID |
Industrials |
$622 |
Notice of FY26 Result & Investor Briefing
|
30 Jul 2026 8:48AM |
$4.850 |
$5.980 |
risen by
23.30%
|
|
| Aussie Broadband Limited (ABB) ORDINARY FULLY PAID |
Communication Services |
$1,571 |
ABB FY26 Results Release Date and Investor Briefing
|
30 Jul 2026 8:48AM |
$4.810 |
$4.980 |
risen by
3.53%
|
|
| Comet Ridge Limited (COI) ORDINARY FULLY PAID |
Energy |
$134 |
Results of Share Purchase Plan
|
30 Jul 2026 8:47AM |
$0.088 |
$0.084 |
fallen by
4.55%
|
|
| HitIQ Limited (HIQ) ORDINARY FULLY PAID |
Health Care |
$6 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
30 Jul 2026 8:46AM |
$0.006 |
$0.006 |
fallen by
0%
|
|
HIQ - Price-sensitive ASX Announcement
Full Release
Key Points
- Secured $1.4 million capital raising to strengthen the balance sheet.
- Signed a Victorian Government Grant Agreement for non-dilutive funding.
- Invested in expanding Victorian manufacturing capability and engineering resources.
- Focused on product development, manufacturing efficiency, and supply chain optimization.
- Continued commercial expansion across retail, universities, and defence markets.
- Improved financial flexibility by drawing down on a $1.0 million working capital facility.
- Achieved significant progress in the Victorian Government Commercialisation Program.
- Targeted growth in the global concussion management market with advanced technology.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ausquest Limited (AQD) ORDINARY FULLY PAID |
Materials |
$80 |
Quarterly Activities and Cashflow Report
|
30 Jul 2026 8:46AM |
$0.040 |
$0.049 |
risen by
22.50%
|
|
AQD - Price-sensitive ASX Announcement
Full Release
Key Points
- Significant porphyry copper discovery at Cangallo.
- RC drilling results demonstrate promising copper grades.
- Full ownership of exploration tenements in Australia and Peru.
- Activities focused on expanding resource base and exploration potential.
- Cashflow report reflects exploration and corporate expenses.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Audeara Limited (AUA) ORDINARY FULLY PAID |
Consumer Discretionary |
$6 |
Investor Update June 2026
|
30 Jul 2026 8:45AM |
$0.030 |
$0.032 |
risen by
6.67%
|
|
| DigitalX Limited (DCC) ORDINARY FULLY PAID |
Information Technology |
$38 |
Update - Notification of buy-back - DCC
|
30 Jul 2026 8:44AM |
$0.027 |
$0.027 |
fallen by
0%
|
|
Call 1300 880 160
Start a chat
Schedule a call
